Correlation Between Day One and Clearmind Medicine

Can any of the company-specific risk be diversified away by investing in both Day One and Clearmind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Clearmind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Clearmind Medicine Common, you can compare the effects of market volatilities on Day One and Clearmind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Clearmind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Clearmind Medicine.

Diversification Opportunities for Day One and Clearmind Medicine

0.48

Correlation Coefficient

Day One  Clearmind Medicine

Very weak diversification

The 3 months correlation between Day and Clearmind is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Clearmind Medicine Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearmind Medicine Common and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Clearmind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearmind Medicine Common has no effect on the direction of Day One i.e., Day One and Clearmind Medicine go up and down completely randomly.

Pair Corralation between Day One and Clearmind Medicine

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.41 times more return on investment than Clearmind Medicine. However, Day One Biopharmaceuticals is 2.42 times less risky than Clearmind Medicine. It trades about -0.01 of its potential returns per unit of risk. Clearmind Medicine Common is currently generating about -0.05 per unit of risk. If you would invest  1,934  in Day One Biopharmaceuticals on September 14, 2024 and sell it today you would lose (653.00) from holding Day One Biopharmaceuticals or give up 33.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.8%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Clearmind Medicine Common

Day One Biopharmaceu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Clearmind Medicine Common

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Clearmind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Day One and Clearmind Medicine

The main advantage of trading using opposite Day One and Clearmind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Clearmind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearmind Medicine will offset losses from the drop in Clearmind Medicine's long position.

The idea behind Day One Biopharmaceuticals and Clearmind Medicine Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.